Follow
Brianna Lax
Brianna Lax
Postdoctoral Fellow, Technical University of Denmark
Verified email at biosustain.dtu.dk
Title
Cited by
Cited by
Year
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
EA Lutz, Y Agarwal, N Momin, SC Cowles, JR Palmeri, E Duong, V Hornet, ...
Proceedings of the National Academy of Sciences 119 (36), e2205983119, 2022
182022
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
BM Lax, JR Palmeri, EA Lutz, A Sheen, JA Stinson, L Duhamel, ...
Proceedings of the National Academy of Sciences 120 (31), e2300895120, 2023
82023
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
SC Cowles, A Sheen, L Santollani, EA Lutz, BM Lax, JR Palmeri, ...
MAbs 14 (1), 2088454, 2022
82022
Yeast surface display for protein engineering: library generation, screening, and affinity maturation
BH Kang, BM Lax, KD Wittrup
Yeast Surface Display, 29-62, 2022
52022
Tregs constrain CD8+ T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy
JR Palmeri, BM Lax, JM Peters, L Duhamel, JA Stinson, L Santollani, ...
Biorxiv, 2023
22023
CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs
JR Palmeri, BM Lax, JM Peters, L Duhamel, JA Stinson, L Santollani, ...
Nature Communications 15 (1), 1900, 2024
12024
Mechanistic Elucidation and Therapeutic Improvement of Anti-CTLA-4 Therapies
BM Lax
Massachusetts Institute of Technology, 2023
2023
Correction to: Yeast Surface Display for Protein Engineering: Library Generation, Screening, and Affinity Maturation
BH Kang, BM Lax, KD Wittrup
Yeast Surface Display, C1-C1, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8